Author Question: A patient who is at risk for DVT tells the primary care NP she has just learned she is pregnant. The ... (Read 117 times)

urbanoutfitters · **on:** Jul 24, 2018

A patient who is at risk for DVT tells the primary care NP she has just learned she is pregnant. The NP should expect that this patient will use which of the following anticoagulant medications?

a. Aspirin
b. Heparin
c. Dabigatran
d. Warfarin

Question 2

A patient who has disabling intermittent claudication is not a candidate for surgery. Which of the following medications should the primary care NP prescribe to treat this patient?

a. Cilostazol (Pletal)
b. Warfarin (Coumadin)
c. Pentoxifylline (Trental)
d. Low-dose, short-term aspirin

dantucker · **Reply #1 on:** Jul 24, 2018

Answer to Question 1

B
Heparin does not cross the placental barrier and is the drug of choice for anticoagulation therapy during pregnancy, despite its category C classification. Aspirin is not recommended during the last 3 months of pregnancy. Dabigatran is not recommended. Warfarin crosses the placental barrier.

Answer to Question 2

A
Patients with disabling intermittent claudication who are not candidates for surgery or catheter-based intervention should be treated with cilostazol rather than pentoxifylline. Warfarin is not indicated. Patients with chronic limb ischemia are treated with lifelong aspirin therapy.